Evaluating the user experience with Omnipod 5 in people with type-1 Diabetes.
Type 1 diabetes (T1D) is a condition where the body’s immune system mistakenly attacks the cells in the pancreas that make insulin. Insulin is the hormone that helps move sugar from the bloodstream into the body’s cells to be used for energy. Without enough insulin, blood sugar levels rise too high. Because people with T1D can’t make their own insulin, they need to take it every day either through multiple daily injections or by using an insulin pump, which is a small wearable device that delivers insulin under the skin throughout the day.
The Omnipod 5 is a newer type of insulin pump that is tubeless and sticks directly onto the skin. It works together with a continuous glucose monitor (CGM), a sensor that tracks blood sugar levels all the time. The system can automatically adjust how much insulin it gives based on those glucose readings. Since it doesn’t have tubes and can manage insulin delivery on its own, it may feel easier, more comfortable, and more convenient than traditional pumps or injections.
Most previous studies on insulin pumps have mainly focused on blood sugar numbers. However, living with diabetes is about much more than just glucose levels. It can affect sleep, daily routines, stress levels, and overall quality of life. This study aims to better understand what it’s actually like for people to use the Omnipod 5 compared to their usual treatment, whether that’s injections with a CGM or a traditional pump with tubing.
The study will include 74 adults with T1D, who will be randomly placed into one of two groups. One group will use the Omnipod 5, and the other will continue with their usual care for six months. Researchers will look at sleep, physical activity, quality of life, and health outcomes to see whether the Omnipod 5 improves everyday life and diabetes management.